New Build Report: Pharmaceutical-Biotech Sector to Open 113 New Facilities in 2015 with $4.7 Billion in Capital Investment Potential
New Build Report: Pharmaceutical-Biotech Sector to Open 113 New Facilities in 2015 with $4.7 Billion in Capital Investment Potential
SUGAR LAND--January 23, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 113 reported new facility builds in the Pharmaceutical-Biotech Industry that are scheduled to open their doors by the end of the year, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites potentially represent a total capital investment of $4.7 billion, which translates to a per-site average of about $41.5 million.
Within this article: Details on key projects from major companies, such as Colgate-Palmolive (NYSE:CL), Thermo Fisher Scientific Incorporated (NYSE:TMO) and Church & Dwight Incorporated (NYSE:CHD).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mid-Atlantic Lays Claim to Majority of Pharma-Biotech's $3.5 Billion Invest...
- Thermo Fisher Scientific Sees Record Third Quarter, Thanks to Growth in Chi...
- Food, Pharma Lift Kansas to $3 Billion in Projects Under Construction
- South Carolina Sees More than $4 Billion in Projects Under Construction
- Energy, Other Key Industries in Less Metropolitan U.S. States Feel COVID-19...